CELLforCURE by Seqens

CELLforCURE by Seqens is a leading biotechnology research company, specializing in the development and commercial manufacturing of advanced therapy medicinal products (ATMPs). With over a decade of experience, CELLforCURE by Seqens offers comprehensive end-to-end services, supporting projects from Phase I trials to full-scale commercial production. This commitment to innovation positions CELLforCURE by Seqens as a key partner in the biotechnology sector.

Operating from a state-of-the-art “one-stop-shop” facility near Paris, CELLforCURE by Seqens provides 10,000 sqm of space, including 2,200 sqm of GMP-certified production areas. These facilities include 7 independent manufacturing lines, each featuring 8 cleanrooms designed to ensure maximum safety and regulatory compliance. The primary address of CELLforCURE by Seqens is 11 Av. des Tropiques, Les Ulis, 91940, France.

CELLforCURE by Seqens distinguishes itself through its unique blend of CDMO heritage and proven commercial manufacturing expertise. By facilitating seamless project development and leveraging in-house Quality Control for a significant portion of processes, CELLforCURE by Seqens ensures the delivery of high-quality drug products. We invite the management team to enhance this description with a customized company showcase and product listing on our platform, providing an exclusive opportunity to further highlight your capabilities and drive commercial success.